drug-induced liver injury
Conditions
Interventions
Liver protection program 1 group:none
joint programme group:none
Sponsors
Beijing Chest Hospital,Capital Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Diagnosis of various types of tuberculosis; 2. Diagnosis of liver injury/liver damage/abnormal liver function/hepatic insufficiency/increased transaminase/hyperbilirubinemia, etc.; 3. Test items ALT, AST, ALP, TBIL Other indicators are abnormal; 4. Hepatoprotective drugs are used. If 1 and any one of 2, 3, and 4 are satisfied, it will be included.
Exclusion criteria
Exclusion criteria: 1. Anti-tuberculosis drug RUCAM score < 3 points. 2. Incomplete information or lack of key information such as the results of liver biochemical tests and the use of liver-protecting drugs. 3. Combined viral liver disease/alcoholic liver disease/non-alcoholic fatty liver disease/autoimmune liver disease/cholestatic disease/genetic metabolic liver disease. 4. Combined with other diseases that may cause abnormal liver biochemical indicators.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ALT;TBIL;ALP; | — |
Countries
China
Contacts
Public ContactLiuShuo
Beijing Chest Hospital,Capital Medical University
Outcome results
None listed